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Introduction
Adipose tissue plays a prominent role in metabolic regulation, 
and dysregulation of adipose tissue storage is a risk factor for car-
diometabolic disease (1). Sex is a key determinant in the regula-
tion of adipose tissue storage and distribution (2–4). Women tend 
to store fat subcutaneously in the femorogluteal area, whereas 
men and postmenopausal women tend to accumulate fat in the 
abdominal region (3). Estrogen replacement in postmenopausal 
women reduces central adipose tissue, which has focused atten-
tion on gonadal hormones as a key mediator of sex differences in 
adiposity (5, 6).
In addition to gonadal hormones, there is evidence that genet-
ic factors that differ between males and females influence body 
fat. For example, male and female mouse and human embryos 
differ in body composition even before gonadal development (7, 
8). The key genetic difference between females and males is the 
presence of XX versus XY chromosomes. Since individuals with 
XX chromosomes typically have female gonads and those with XY 
chromosomes have male gonads, it is difficult to ascertain the con-
tributions of each component to a trait such as adiposity. Howev-
er, evidence for a role of sex chromosome complement in human 
adiposity comes from studies of Klinefelter syndrome subjects 
(XXY), who have increased body fat mass compared with matched 
XY counterparts, even before puberty (9, 10). However, the mech-
anisms underlying the apparent effects of X chromosome dosage 
effects on adiposity in these individuals are not understood.
To better distinguish the contributions of gonads and sex 
chromosomes to adiposity, we used the four core genotypes (FCG) 
mouse model, which generates XX and XY mice with ovaries and 
XX and XY mice with testes (11). Analysis of these 4 genotypes 
allows a determination of whether a specific trait is influenced 
by gonadal sex (ovaries, female; or testes, male), chromosomal 
sex (XX or XY), or an interaction between the two (12). We previ-
ously demonstrated that if adult FCG mice are gonadectomized 
to remove the acute effects of gonadal hormones, XX mice with 
ovaries or testes develop increased adiposity compared with XY 
mice with ovaries or testes (13). Furthermore, we determined that 
the presence of 2 copies of the X chromosome was responsible for 
increased adiposity in gonadectomized XX mice, regardless of the 
presence of a Y chromosome.
A likely mechanism by which the XX chromosome comple-
ment could influence sex differences is through the expression of 
genes that escape X chromosome inactivation (14). In mammals, 
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and testes) from chromosomal sex (XX and XY), we showed that XX chromosome complement in combination with a high-fat 
diet led to enhanced weight gain in the presence of male or female gonads. We identified the genomic dosage of Kdm5c, an 
X chromosome gene that escapes X chromosome inactivation, as a determinant of the X chromosome effect on adiposity. 
Modulating Kdm5c gene dosage in XX female mice to levels that are normally present in males resulted in reduced body 
weight, fat content, and food intake to a degree similar to that seen with altering the entire X chromosome dosage. In cultured 
preadipocytes, the levels of KDM5C histone demethylase influenced chromatin accessibility (ATAC-Seq), gene expression 
(RNA-Seq), and adipocyte differentiation. Both in vitro and in vivo, Kdm5c dosage influenced gene expression involved in 
extracellular matrix remodeling, which is critical for adipocyte differentiation and adipose tissue expansion. In humans, 
adipose tissue KDM5C mRNA levels and KDM5C genetic variants were associated with body mass. These studies demonstrate 
that the sex-dependent dosage of Kdm5c contributes to male/female differences in adipocyte biology and highlight X-escape 
genes as a critical component of female physiology.
X chromosome dosage of histone demethylase KDM5C 
determines sex differences in adiposity
Jenny C. Link,1 Carrie B. Wiese,2 Xuqi Chen,3 Rozeta Avetisyan,2 Emilio Ronquillo,2 Feiyang Ma,4 Xiuqing Guo,5 Jie Yao,5  
Matthew Allison,6 Yii-Der Ida Chen,5 Jerome I. Rotter,5 Julia S. El -Sayed Moustafa,7 Kerrin S. Small,7 Shigeki Iwase,8  
Matteo Pellegrini,4 Laurent Vergnes,2 Arthur P. Arnold,3 and Karen Reue1,2
1Molecular Biology Institute, 2Human Genetics, David Geffen School of Medicine, 3Integrative Biology and Physiology, and 4Molecular, Cellular and Developmental Biology, UCLA, Los Angeles, California, USA. 
5Institute for Translational Genomics and Population Sciences, Department of Pediatrics, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA. 6Division 
of Preventive Medicine, School of Medicine, UCSD, San Diego, California, USA. 7Department of Twin Research and Genetic Epidemiology, King’s College London, London, United Kingdom. 8Human Genetics, 
Medical School, University of Michigan, Ann Arbor, Michigan, USA.
Authorship note: JCL and CBW contributed equally to this work.
Conflict of interest: The authors have declared that no conflict of interest exists.
Copyright: © 2020, American Society for Clinical Investigation.
Submitted: May 13, 2020; Accepted: July 16, 2020; Published: September 28, 2020.
Reference information: J Clin Invest. 2020;130(11):5688–5702. 
https://doi.org/10.1172/JCI140223.
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
5 6 8 9jci.org   Volume 130   Number 11   November 2020
mosome complement on adiposity in gonadally intact animals. 
At 14 weeks of age, mice were fed a high-fat diet (60% calories 
from fat, 26% from carbohydrate) for 10 weeks. All genotypes 
gained weight (Figure 1B), but XX mice with either gonadal type 
increased their body weight by a greater proportion than XY mice 
(Figure 1C). After 10 weeks of a high-fat diet, XX mice had a great-
er percentage of fat mass than XY mice of both gonadal types (Fig-
ure 1, E and F). Gonadal and inguinal fat depots were larger in XX 
compared with XY mice by 34% and 64%, respectively (Figure 
1G). These results indicate that gonadal sex is a primary determi-
nant of body weight and adiposity in mice fed a chow diet and that 
XX chromosome complement promotes accelerated weight and 
fat gain in response to a high-fat diet.
We assessed energy balance in the mice represented in Figure 
1B at 1 week and 8 weeks of high-fat diet feeding. All 4 genotypes 
exhibited typical diurnal variations in locomotor activity (Supple-
mental Figure 1A; supplemental material available online with 
this article; https://doi.org/10.1172/JCI140223DS1). Mice with 
female gonads were more active than those with male gonads, 
as measured by locomotion along the horizontal plane (Supple-
mental Figure 1B). There were no significant differences among 
the genotypes in energy expenditure or respiratory quotient (RQ) 
(Supplemental Figure 1, C and D). After 1 week of a high-fat diet, 
food intake was increased by both XX chromosome complement 
and male gonadal sex during both the dark and light phases (Fig-
ure 1H). After 8 weeks of a high-fat diet, XX chromosomes and 
male gonads led to increased food intake specifically during the 
light phase of the circadian cycle (Figure 1H). Thus, energy bal-
ance is influenced by a complex interplay among sex chromosome 
complement, gonadal type, and the circadian cycle.
We also examined the contributions of gonadal and sex chro-
mosome types to glucose homeostasis at 10 weeks of high-fat 
feeding. Males had higher fasting glucose and insulin levels as 
well as higher homeostatic model assessment–estimated insulin 
resistance (HOMA-IR) compared with females (Supplemental 
Figure 2A). Insulin levels and HOMA-IR values were also higher 
in XX compared with XY mice. The presence of female gonads led 
to more rapid clearance of the glucose bolus in glucose tolerance 
tests (Supplemental Figure 2B). These results suggest compound 
effects of gonadal and chromosomal sex on glucose homeostasis in 
response to a high-fat diet.
Kdm5c gene dosage recapitulates X chromosome dosage effects on 
adiposity. We hypothesized that differences between XX and XY 
mice in diet-induced adiposity are related to higher expression 
levels of specific X chromosome genes that escape silencing by X 
chromosome inactivation (15, 16). We previously demonstrated 
that such X-escape genes exhibit higher mRNA expression levels 
in tissues of XX compared with XY mice that had been gonadec-
tomized (13). Four genes in particular showed robust differences 
in expression levels based on X chromosome dosage — Kdm5c, 
Kdm6a, Ddx3x, and Eif2s3x. These 4 genes are ubiquitously 
expressed across tissues (18), and we found that they exhibit ele-
vated expression in XX compared with XY mouse subcutaneous 
and gonadal adipose tissue depots in gonadally intact mice fed a 
high-fat diet for 10 weeks (Figure 2, A–D). The X-escape genes are 
also expressed at higher levels in human tissues from females com-
pared with males, as illustrated for human KDM5C (Figure 2E).
the X chromosome carries more than 800 protein coding genes 
that are not present on the Y chromosome, such that XX females 
have a double genomic dose of these genes compared with XY 
males. To normalize the expressed dosage of X chromosome 
genes between the sexes, most genes on 1 X chromosome in XX 
cells are transcriptionally silenced early in development through X 
chromosome inactivation. However, some X chromosome genes 
escape inactivation to varying degrees and are expressed from 
both alleles in XX cells (15, 16). These “X-escape genes” are often 
conserved between mouse and human, and several have functions 
that could influence gene or protein expression broadly across 
the genome. We previously identified 4 X-escape genes that are 
expressed at more than 50% higher levels in XX compared with 
XY metabolic tissues and include histone modifying enzymes, an 
RNA helicase, and a translation initiation factor (13). We hypothe-
size that the differential genomic dosage of X-escape genes in XX 
compared with XY cells contributes to sex differences in cell pro-
cesses that lead to metabolic phenotypes.
In this study, we identify a role for X chromosome dosage in 
determining diet-induced weight gain in mice with intact ovaries 
or testes. Subsequently, we identify the X-escape gene Kdm5c as 
a key contributor to X chromosome dosage effect on adiposity. 
Kdm5c (also known as Jarid1c) encodes a histone demethylase, 
which removes tri- and dimethyl marks from histone 3 lysine 4 
(H3K4) to regulate chromatin access by transcription factors (17). 
By modulating Kdm5c levels in the mouse, we demonstrate that 
Kdm5c gene dosage is a determinant of sex differences in adipos-
ity. We further characterize the role of Kdm5c dosage in chromatin 
landscape, gene expression, and differentiation of cultured preadi-
pocytes. Finally, we assess the association of KDM5C gene expres-
sion levels and genetic variation with human body weight traits.
Results
An XX chromosome complement accelerates diet-induced weight gain 
in mice with male or female gonads. In our previous study, we detect-
ed effects of sex chromosome complement on adiposity in FCG 
mice that had been gonadectomized to remove the acute effects of 
gonadal secretions (13). We assessed whether the influence of sex 
chromosome complement on body weight is evident in the pres-
ence of circulating gonadal hormones in adult C57BL/6 FCG mice. 
In mice fed a standard chow diet (~6% of calories from fat), those 
with testes weighed more than those with ovaries from 10–32 weeks 
of age, regardless of XX or XY chromosome complement (Figure 
1A). More in-depth analysis of a separate cohort of chow-fed mice 
at 14 weeks of age revealed effects of both gonadal and chromo-
somal components on body weight parameters. Body weight was 
higher in mice with male compared with female gonads by an aver-
age of 6.1 grams, but XX mice also had higher body weight than XY 
by nearly 2 grams (Figure 1D). Body composition was influenced 
primarily by gonadal type, with gonadal males having 44% high-
er absolute lean mass and gonadal females having a greater pro-
portion of body mass as fat (fat mass %) (Figure 1D). Interactions 
between sex chromosomes and gonadal type were also noted in the 
percentages of fat and lean mass (Figure 1D).
We previously noted that a high-fat diet amplified the effect 
of sex chromosome complement on adiposity in mice following 
gonadectomy (13). Here, we assessed the contribution of sex chro-
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Figure 1. XX mice gain more weight than XY mice on a high-fat diet. (A) Body weight curves of gonadally intact FCG mice fed a chow diet. XX and XY refer 
to chromosome type; F, female gonads (ovaries); M, male gonads (testes). n = 11 XX female; n = 11 XX male; n = 12 XY female; n = 16 XY male. (B) Body weight 
and (C) percentage weight gained in FCG mice over 10 weeks on high-fat diet, starting at 14 weeks of age. n = 8 mice per genotype (B–G). (D) Body weight, fat 
mass, lean mass, percentage of fat mass, and percentage of lean mass on chow and (E) after 10 weeks of high-fat feeding. (F) Representative mice after 10 
weeks of high-fat diet (individuals with median body weight shown for each genotype). (G) Gonadal and inguinal fat pad mass normalized to kidney mass. 
(H) Food intake measured at 1 week (left) and at 8 weeks (right) of high-fat diet feeding during the dark (black horizontal bar) and light (white horizontal 
bar) periods of the circadian cycle (note different y axis scales). n = 4 mice per genotype. Data are represented as mean ± SD. Data in A–C were analyzed by 
repeated measures 3-way ANOVA (factors of gonadal sex, sex chromosomes, and age). Data in D–H were analyzed by 2-way ANOVA. Statistically significant 
differences for sex chromosome complement and for gonadal sex are denoted by brackets. Int., significant interactions of sex chromosome complement and 
gonadal sex. *P < 0.05; **P < 0.01; ***P < 0.001; †P < 0.0001; ‡P < 0.00001. HFD, high-fat diet.
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fat at 26 weeks of age (Figure 3, B and C). On the high-fat diet, 
Kdm5c+/+ mice gained weight more rapidly than Kdm5c+/– mice, 
with a body weight increase of 75% and 30%, respectively, over 13 
weeks of high-fat diet feeding (Figure 3E). Percentage of fat mass 
was nearly 30% higher in Kdm5c+/+ compared with Kdm5c+/– mice 
after 8 weeks on the high-fat diet (Figure 3F). The reduced body 
weight in Kdm5c+/– mice was associated with reduced food intake 
during the light phase of the circadian cycle (Figure 3, D and G). 
Thus, Kdm5c genomic dosage had an impact that mirrored the 
effect of X chromosome dosage on body fat, weight gain, and food 
intake reported in our previous studies (13, 20).
Kdm5c gene dosage influences gene expression and chromatin 
structure during adipogenesis. Kdm5c gene dosage influenced adi-
pocyte size distribution in vivo. Quantitation of adipocyte size in 
histological sections from inguinal white adipose tissue of mice 
fed a high-fat diet for 10 weeks revealed a shift in the distribution 
toward larger adipocytes in Kdm5c+/– compared with Kdm5c+/+ 
mice (Figure 4A). We hypothesized that KDM5C may influence 
We selected Kdm5c as a candidate gene to test for the X 
chromosome effect on adiposity. Supporting evidence for this 
candidate includes a previous report showing that members of 
the KDM5 gene family of histone demethylases influence adi-
pocyte differentiation in cultured cells (19). To test this candi-
date, we generated WT (Kdm5c+/+) and hemizygous (Kdm5c+/–) 
mice on a C57BL/6 background. All mice were XX female mice, 
such that the only difference was the presence of 1 versus 2 func-
tional Kdm5c gene alleles. Male mice were not studied because 
Kdm5c–/Y male embryos were nonviable on the inbred C57BL/6 
background, possibly reflecting a requirement for KDM5C to 
support fetal development.
The reduced Kdm5c genomic dose in Kdm5c+/– mice reduced 
the levels of KDM5C protein to approximately half the levels 
observed in tissues of Kdm5c+/+ littermates (Figure 3A). This was 
comparable to the differential KDM5C protein levels in XX com-
pared with XY mouse tissues (Figure 3A). On a chow diet, Kdm5c+/– 
mice had lower body weight throughout life and 20% lower body 
Figure 2. Genes that escape X inactivation have elevated expression 
in XX vs. XY mice, and female versus male human tissues. mRNA 
expression levels of Kdm5c (A), Kdm6a (B), Ddx3x (C), and Eif2s3x 
(D) in gonadal fat and inguinal fat depots of gonadally intact FCG 
mice fed a high-fat diet for 10 weeks as determined by qPCR. n = 8 
per genotype. Expression was normalized to 36B4 mRNA levels. (E) 
Expression of human KDM5C in metabolic tissues (subcutaneous 
adipose, visceral adipose, hypothalamus, liver, skeletal muscle, 
pancreas, and small intestine [Sm intest]). Data are from the GTEx 
Project (51). For A–D, data are represented as mean ± SD, and data 
were analyzed by 2-way ANOVA. Significant comparisons for sex 
chromosome complement and for gonadal sex are denoted by brack-
ets. *P < 0.05; **P < 0.01; ***P < 0.001; †P < 0.0001; ‡P < 0.00001.
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assessed by oil red O staining and quantitation) by more than 50% 
in mature adipocytes that were assessed 6 days after addition of 
differentiation cocktail (Figure 4G).
We hypothesized that Kdm5c dosage influences adipogen-
esis through its role in histone modification to regulate genome 
access to transcription factors. We assessed the effects of Kdm5c 
knockdown in 3T3-L1 preadipocytes on chromatin accessibility 
(ATAC-Seq) and gene expression (RNA-Seq) in 3T3-L1 preadipo-
cytes. Kdm5c siRNA was administered 1 day before preadipocyte 
confluence (day –3), and RNA-Seq and ATAC-Seq analyses were 
performed at confluence (day –2) and for 2 subsequent days (day 
–1 and day 0) (Figure 5A). Comparison of the transcriptional pro-
file between Kdm5c knockdown and control cells (treated with a 
nonspecific siRNA) revealed differential gene expression as early 
as 1 day after knockdown, with increasing numbers of differential-
ly expressed genes on each subsequent day (Figure 5A). Analysis 
of differentially expressed genes revealed several pathways that 
were significantly enriched (Figure 5A). The top pathway (adjust-
ed P < 10–5) contained genes implicated in extracellular matrix 
(ECM) remodeling (Figure 5A), a process that is critical during the 
early stages of adipocyte differentiation as well as in the mainte-
the recruitment of preadipocytes to differentiate into adipocytes 
during diet-induced adipose tissue expansion. To explore this, 
we investigated the relative levels of KDM5C protein in preadipo-
cytes and mature adipocytes in mouse adipose tissue and in the 
3T3-L1 preadipocyte cell line. We fractionated white and brown 
adipose tissues from C57BL/6J mice into stromal vascular cells 
and mature adipocytes. KDM5C protein was present almost exclu-
sively in the stromal vascular fraction (Figure 4B), which contains 
adipocyte stem cells as well as endothelial and immune cell types 
(21). In 3T3-L1 cells, Kdm5c mRNA was present in preadipocytes 
and throughout adipocyte maturation, but KDM5C protein was 
detected primarily in preadipocytes and was extinguished as cells 
differentiated and markers of mature adipocytes appeared (e.g., 
fatty acid binding protein 4 [FABP4]) (Figure 4C).
Our findings focused attention on the potential role of KDM5C 
in preadipocytes. We assessed the effects of manipulating Kdm5c 
levels on preadipocyte replication and differentiation (Figure 
4D). Kdm5c knockdown by 70% to 80% in subconfluent 3T3-L1 
preadipocytes led to a greater than 20% reduction in preadipocyte 
proliferation (Figure 4, E and F). Furthermore, Kdm5c knockdown 
during the preadipocyte period blunted lipid accumulation (as 
Figure 3. Kdm5c dosage affects body weight, fat mass, and food intake. (A) KDM5C protein levels in whole brain extracts of gonadally intact female mice 
with 1 or 2 copies of Kdm5c (left) and in FCG mice (right panel). (B) Growth curves of chow-fed female Kdm5c+/+ mice (n = 18–45) and Kdm5c+/– mice (n = 7–18). 
(C) Percentage fat mass of chow-fed Kdm5c+/+ mice (n = 6) and Kdm5c+/– mice (n = 8) at 26 weeks of age. (D) Food intake of 10-week-old chow-fed Kdm5c+/+ 
mice (n = 20) and Kdm5c+/– mice (n = 13) during dark (black horizontal bar) and light (white horizontal bar) phases. (E) Growth curves of female Kdm5c+/+  
(n = 13) mice and Kdm5c+/– mice fed a high-fat diet (n = 9). (F) Proportional fat mass and (G) food intake of Kdm5c+/+ mice (n = 13) and Kdm5c+/– mice (n = 9) 
after 8 weeks of high-fat diet. Values are represented as mean ± SD. Data were analyzed by ANOVA (for growth curves) or by t test. **P < 0.01.
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Figure 4. Kdm5c gene dosage influences adipocyte size in vivo and adipocyte differentiation in vitro. (A) Adipose tissue histology and adipocyte size 
distribution from inguinal fat pads of Kdm5c+/+ and Kdm5c+/– mice fed a high-fat diet for 10 weeks. Original magnification, ×100. Adipocyte sizes were 
determined from cumulative scoring of adipocytes in histological sections from each of 6 mice per genotype. Size distribution was different between 
the 2 genotypes. Mann-Whitney U test, P < 0.0001. (B) Immunoblot of KDM5C protein in the stromal vascular (SV) fraction, mature adipocyte fraction, 
and whole tissue fractions of brown adipose tissue (BAT), gonadal white adipose tissue (Gon. WAT), and inguinal white adipose tissue (Ing. WAT) from 
C57BL/6J female mice (30 μg protein loaded per each lane). MW, molecular weight standards. Western blots are representative of 2 experiments. (C) 
Kdm5c mRNA (upper) and protein levels (lower) in differentiating 3T3-L1 preadipocytes from 2 days before confluence through day 8 after addition of 
differentiation cocktail (25 μg protein loaded per lane). FABP4 is expressed in mature adipocytes; GAPDH was used as loading control. Western blots are 
representative of 2 or more experiments. (D) Timeline of Kdm5c knockdown in 3T3-L1 preadipocytes and collection of samples analyzed in E–G. (E) Kdm5c 
mRNA levels in 3T3-L1 preadipocytes after siRNA knockdown performed at day –3 relative to confluence. Data are representative of 3 experiments. (F) Cell 
number increases in 3T3-L1 preadipocytes transfected 3 days before confluence with Kdm5c or nonspecific siRNA. n = 4 samples per treatment. Data are 
representative of 2 experiments. (G) Appearance and quantification of oil red O staining in 3T3-L1 cells after knockdown at day –3 and harvest at day 6 of 
adipocyte differentiation. Scale bar: 200 μm. n = 6 samples per treatment. Data are representative of 2 experiments. **P < 0.01; ***P < 0.0001.
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nance and expansion of adipose tissue mass (22). Differentially 
expressed genes involved in ECM organization included matrix 
metalloproteinases (Mmp3, Mmp9, Mmp13), metallopeptidases 
(Adamts1, Adamts2, Adamts5, Adamts14), and integrins (Itga2, 
Itga3, Itga7, Itgb7, Itgb8) (Supplemental Figure 3). Additional 
enriched pathways (adjusted P < 0.035 to 10–3) included immune 
signaling and interleukin pathways (Figure 5A; see also Supple-
mental Figure 3).
Figure 5. Kdm5c knockdown in preadipocytes alters gene expression and chromatin accessibility at promoters enriched in adipogenic transcription fac-
tor motifs. (A) Differential gene expression induced by Kdm5c knockdown in 3T3-L1 preadipocytes. Top: timeline of sample generation (n = 5 samples for 
each treatment at each time point). Volcano plots show genes that are differentially expressed (EdgeR) in response to Kdm5c knockdown (light blue dots). 
Differentially expressed genes with greater than 1.25-fold difference were analyzed for pathway enrichment, and genes belonging to 3 most significant 
pathways are highlighted with colored dots: red dots, genes involved in ECM organization (ECM); dark blue dots, genes in immune signaling pathways; 
purple dots, genes in interleukin pathway. (B) ATAC-Seq analysis of the same samples in A showed altered chromatin accessibility after Kdm5c knockdown 
at genomic locations indicated (n = 4 samples for each treatment at each time point). Alterations at proximal gene promoters (within 1.5 kb of transcrip-
tion start sites) progressively increased each day after knockdown. (C) Differentially expressed genes from day 0 were overlaid with differential ATAC-Seq 
promoter peaks from day 0, and 48% of the corresponding genes showed overlap in the 2 data sets. (D) Genes that showed differential mRNA expression 
and ATAC-Seq promoter peaks showed enrichment for specific transcription factor motifs in the promoter region.
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genes were also significantly altered by Kdm5c knockdown in 3T3-
L1 cells (Figure 6, A and B). Since KDM5C protein levels are low in 
mature adipocytes (Figure 4B), the altered gene expression that 
we observed in mature adipocytes of Kdm5c+/– mice may reflect 
events during early stages of adipocyte differentiation. Pathway 
enrichment analysis showed strong similarities between in vivo 
gene expression alterations due to Kdm5c haploinsufficiency and 
the effects of Kdm5c knockdown in 3T3-L1 preadipocytes. In par-
ticular, reduced Kdm5c dosage both in vivo and in vitro altered 
gene expression related to ECM remodeling and immune and 
interferon signaling pathways (Figure 6C). These results illustrate 
that modulation of Kdm5c genomic dose from levels normally 
present in females to levels normally present in males elicits sub-
Histone demethylases act to establish or maintain open or 
closed chromatin states. We performed ATAC-Seq (23) to identify 
regions of open chromatin that are influenced by Kdm5c levels in 
3T3-L1 cells. Kdm5c knockdown in 3T3-L1 preadipocytes resulted 
in significant differential accessibility across the genome (Figure 
5B). A focus on differential ATAC-Seq peaks that occurred within 
promoter regions (1 kb upstream and 0.5 kb downstream from the 
transcription start site) identified 441 gene promoters with dif-
ferential peaks in control compared with Kdm5c knockdown cells 
(based on DESeq2 analysis, P < 0.05). At day 0, nearly half of the 
genes that were differentially expressed after Kdm5c knockdown 
also showed an enrichment in ATAC-Seq peaks in the proximal 
promoter (Figure 5C and Supplemental Figure 4), suggesting that 
these may be genomic sites at which KDM5C levels influence gene 
expression through alterations in chromatin accessibility. Among 
these sites, there was an enrichment for targets of transcription 
factors such as C/EBPβ, CREB1, and KLF (Figure 5D), which have 
known roles in adipogenesis (24–26).
The studies of Kdm5c knockdown in 3T3-L1 cells revealed 
pathways that are proximal targets of KDM5C action in cultured 
preadipocytes. To verify these results in vivo, we compared gene 
expression in subcutaneous adipose tissue from Kdm5c+/+ and 
Kdm5c+/– mice. Adipose tissue was fractionated into stromal vas-
cular and mature adipocytes for RNA-Seq analysis. Kdm5c hap-
loinsufficiency caused altered gene expression in both fractions 
(Figure 6, A and B), and many of these differentially expressed 
Figure 6. Modulation of Kdm5c gene 
dosage in vivo alters adipose tissue 
gene expression in ECM organization 
and immune signaling pathways. 
RNA-Seq was performed in (A) stromal 
vascular (SV) and (B) mature adipocyte 
(MAT) fractions of inguinal fat from 
Kdm5c+/+ and Kdm5c+/– mice (n = 3 mice 
per genotype). Volcano plots show 
genes that are differentially expressed 
(EdgeR) between the 2 genotypes (light 
blue) and genes that also belong to 
the pathways that were enriched after 
Kdm5c knockdown in 3T3-L1 preadipo-
cytes from Figure 5A (gold dots). (C) 
Pathways that are enriched for genes 
differentially expressed between both 
Kdm5c+/+ and Kdm5c+/– adipose tissue 
fractions (>1.25-fold) and in Kdm5c 
knockdown in 3T3-L1 cells.
Table 1. KDM5C genetic association with BMI  
adjusted for waist-to-hip ratio
Group KDM5C variant P value Significance threshold
AA men chrX:53243061:D 0.0002 0.0014
HA men rs116253736 0.0033 0.0021
HA women rs146319621 0.0052 0.0125
rs141945503 0.0052 0.0125
Sample-specific significance thresholds calculated based on number of 
variants and linkage blocks.
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Model for the role of sex differences in KDM5C dosage and adi-
posity. Taken together, our results demonstrate that inherent 
differences between males and females in the genomic dos-
age of the X chromosome — and specifically, the Kdm5c gene 
— influence adipose tissue accrual and diet-induced expansion 
in the mouse (Figure 7). The increased genomic dose of Kdm5c 
in XX compared with XY cells leads to elevated expression due 
to escape from X chromosome inactivation. Presumably related 
to the KDM5C histone demethylase activity, the higher KDM5C 
levels in XX cells influence the chromatin landscape and gene 
expression in preadipocytes to modulate genes involved in ECM 
remodeling and other processes. Consistent with the results in 
our model systems, individual differences in KDM5C expression 
levels and genetic variants in the KDM5C gene are also associat-
ed with adiposity traits in humans.
Discussion
Sex has a strong influence on fat accumulation and distribution. 
Traditionally, sex differences in adiposity have been attributed to 
gonadal hormones. Using mice in which gonadal type segregates 
independently from sex chromosome complement, we found that 
gonads are the key determinant of adiposity in mice fed a chow 
diet, but that XX chromosome complement promotes more rapid 
weight and fat accumulation than XY in response to a high-fat diet. 
We hypothesized that the higher genome dose and expression 
levels of specific genes that escape X chromosome inactivation 
contribute to the differences between XX and XY mice. We tested 
Kdm5c as a candidate for X chromosome dosage effects on adi-
posity and demonstrated that modulation of Kdm5c gene dosage 
closely replicated several features of modulating X chromosome 
dosage, including effects on body fat composition, weight gain on 
a high-fat diet, and increased food intake during the inactive part 
of the circadian cycle. We also demonstrated a role for Kdm5c dos-
stantial differences in adipose tissue gene expression and affects 
processes that are implicated in adipocyte differentiation and 
adipose tissue expansion.
KDM5C mRNA correlation with BMI and genetic variants 
associated with human adiposity. Our studies in the mouse and 
in cultured cells establish a positive relationship between Kdm5c 
levels and adiposity. To determine whether this relationship is 
conserved in humans, we assessed whether KDM5C expression 
levels are correlated with BMI and whether genetic variation at 
the KDM5C locus is associated with body weight traits. An anal-
ysis of KDM5C gene expression in adipose tissue of 776 female 
twins from the TwinsUK cohort (27) revealed a strong positive 
correlation between KDM5C expression and BMI (P = 5 × 10–10) 
(Supplemental Figure 5).
To assess whether genetic variation at the KDM5C gene locus 
might influence body weight characteristics, we tested variants 
spanning the KDM5C gene for association with BMI adjusted for 
waist-to-hip ratio in the Multi-Ethnic Study of Atherosclerosis 
(28). We assessed association in 3 ethnic groups that each had 700 
or more samples for each sex: African American (AA), Hispan-
ic American (HA), and European American (EA). We performed 
association analyses in men and women separately within each 
ethnic group, and the variants that met requirements for associa-
tion analysis in each group are shown in Supplemental Figure 6. To 
correct for multiple testing, we adjusted for linkage disequilibrium 
(LD) among the SNPs analyzed and calculated significant P values 
for each group, as delineated in Methods. Due to differential LD 
structure by ethnic group and sex (Supplemental Figure 7), distinct 
P values were calculated for each group. Applying these criteria, 
we found significant associations between adiposity traits and 
KDM5C noncoding variants in AA men, HA men, and HA women 
(Table 1 and Supplemental Figure 6). We did not detect associa-
tions in EA samples.
Figure 7. Proposed mechanism for X chromosome dosage effects on adiposity. The Kdm5c genomic dose present in XX cells (upper panel) leads to higher 
levels of KDM5C histone demethylase than in cells with a single Kdm5c gene due to XY or Kdm5c+/– genotype (lower panel). KDM5C protein levels modulate 
histone methylation and influence gene expression and positively correlate with adiposity traits in the mouse and in humans. Xi, transcriptionally inacti-
vated X chromosome; Xa, active X chromosome.
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gain more absolute weight and fat mass than females; however, 
there are numerous mouse strains in which females gain more 
absolute fat mass (40). Furthermore, given the typical differenc-
es in body size between males and females, it is most relevant to 
compare percentage of body weight or fat gained during a high-
fat diet, as we have done in the analysis of our FCG mouse phe-
notypes. Age is also a determinant of sex-dependent response to 
a high-fat diet. In C57BL/6 mice (the genetic background of our 
FCG and Kdm5c haploinsufficient mice), a high-fat diet fed to 
juveniles leads to greater absolute and proportional weight gain in 
males compared with females, but in adult or middle-aged mice 
(similar to ages used in our diet studies), female C57BL/6 mice 
gain a greater proportion of their body weight than males (41). Our 
studies with FCG and Kdm5c “genomic-dose” models vary specif-
ic components of naturally occurring sex differences to demon-
strate that expression of an individual X-escape gene influences 
adipose tissue accrual. The same effects are expected to be active 
in standard XX female versus XY male mice.
The relationship that we observed between KDM5C levels 
and adiposity traits in the mouse are further supported by our 
findings in humans. Specifically, we detected a strong positive 
correlation between adipose tissue KDM5C expression levels 
and BMI and identified genetic variants in human KDM5C that 
are associated with BMI normalized to waist-to-hip ratio. The 
latter trait is notable because waist-to-hip ratio reflects differ-
ences in fat distribution that commonly occur between men and 
women, with men having a propensity to store visceral fat around 
the waist and women typically having more subcutaneous fat in 
the hip region. The genetic associations were most prominent in 
AA and HA men and in HA women. The associations in men may 
be more readily identified because males carry either 0 or 1 copy 
of the minor allele (since they have a single X chromosome), 
whereas women carry 0, 1, or 2 copies, leading to 3 genotypic 
groups for each variant. We therefore require a larger sample to 
detect an association with the same effect size in women com-
pared with men (i.e., at a minor and major allele frequency of p 
and q in a total sample of n, we require sample sizes for women 
of n × p2, n × 2 × p × q, and n × q2 for the 3 genotypic groups, but 
sample sizes of n × p and n × q for the 2 genotypic groups in men). 
Our results in humans support our findings that KDM5C levels 
influence adiposity and also raise the possibility that variations 
in KDM5C-mediated histone modifications may contribute to 
individual differences in obesity.
We propose that genes that escape X inactivation have a role in 
determining several sex differences in normo- and pathophysiolo-
gy. Recently, the X-escape gene Kdm6a was shown to modulate sex 
differences in T cell biology in a mouse model of experimental auto-
immune encephalomyelitis (42). Both Kdm5c and Kdm6a belong to 
a special subgroup of X-escape genes that have paralogous genes on 
the Y chromosome (43). Since these X and Y paralogs do not recom-
bine with one another, they have diverged over evolutionary time 
such that the gene pairs may no longer retain the same molecular 
functions. For example, in the case of Kdm6a (also known as Utx), 
in vivo complementation studies suggest that Uty (the Y chromo-
some paralog of Utx) cannot fully substitute for critical roles of Utx 
during embryonic development (44). The Y chromosome paralog 
of Kdm5c, known as Kdm5d, has been implicated in the regulation 
age on adipocyte proliferation and differentiation, the regulation 
of chromatin accessibility and gene expression, and body weight 
traits in humans.
It is likely that Kdm5c dosage affects very early stages of adipo-
cyte recruitment and differentiation, since we detected KDM5C 
protein in preadipocytes (or the stromal vascular fraction in vivo) 
and not in mature adipocytes. Accordingly, Kdm5c knockdown in 
3T3-L1 preadipocytes led to reduced cell proliferation and reduced 
lipid accumulation after cells were differentiated. The reduced 
lipid accumulation in mature adipocytes following Kdm5c knock-
down in vitro or Kdm5c+/– gene dosage in vivo is likely a reflection 
of fewer cells recruited to differentiate to mature adipocytes, rath-
er than a direct effect of KDM5C on lipid synthesis. As a result, 
mature adipocytes in Kdm5c+/– fat pads may be fewer, but tend 
toward larger sizes, to accommodate greater fat storage per cell in 
mice that are challenged with excess dietary fat. Our results are 
in agreement with the previous demonstration that members of 
the KDM5 family of histone demethylases (Kdm5a, Kdm5b, and 
Kdm5c) influence 3T3-L1 adipogenesis (19). However, Kdm5c is 
unique among the KDM5 genes in its location on the X chromo-
some and its differential expression levels between males and 
females. Kdm5c mRNA is detected in many tissues (although pro-
tein levels have not been assessed), and KDM5C mutations have 
been associated with neurodevelopmental disorders and cancer 
(29, 30). Thus, it is possible that differential Kdm5c levels in non-
adipose tissues (such as hypothalamus) may also contribute to sex 
differences in energy balance.
The modulation of Kdm5c levels was associated with alter-
ations in expression of genes involved in ECM remodeling and 
interferon signaling both in vivo and in vitro. ECM reorganiza-
tion is critical for adipose tissue expansion and occurs through 
the breakdown and resynthesis of proteins, proteoglycans, and 
polysaccharides to allow the enlargement of existing adipocytes, 
adipogenesis from precursor cells, and angiogenesis (31–33). 
Among the ECM genes that were influenced by Kdm5c dosage is 
Mmp3, which encodes a metalloproteinase that is differentially 
expressed in male and female C57BL/6J mouse adipose tissue 
and is associated with sex differences in diet-induced adipose 
tissue expansion (34). Genes associated with interferon signal-
ing were also influenced by Kdm5c dosage. Interferons stimulate 
several transduction pathways that have been associated with 
adipocyte differentiation, including JAK/STAT, MAP kinase, 
and PI3K/AKT pathways (35, 36). Importantly, nearly half of the 
changes in gene expression that resulted from Kdm5c knockdown 
in 3T3-L1 cells correlated with alterations in chromatin accessi-
bility of gene promoters as assessed by ATAC-Seq. This suggests 
that many of the observed alterations in gene expression may 
result from KDM5C-mediated histone modifications at relevant 
gene promoters, but further studies to directly map KDM5C bind-
ing sites in preadipocytes await the availability of an antibody that 
exhibits adequate specificity for genome-wide chromatin immu-
noprecipitation studies.
In mouse models of obesity, a commonly held generalization 
is that a high-fat diet induces greater weight gain in males com-
pared with females (37–39). This is an oversimplification, as sev-
eral factors influence the outcome of a high-fat diet, including 
genetic background and age. In many mouse strains, male mice 
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to food and water. Average RQ, cumulative heat production and cumu-
lative locomotor activity were calculated from the second dark and 
second light intervals of the 72-hour measurement period. Heat pro-
duction was determined as follows: ([3.815 + 1.232 × (observed respira-
tory exchange ratio [RER])] × [observed oxygen consumption (VO2)]). 
This parameter does not contain a body weight term and thus avoids 
complications that could occur due to differences in body weight.
Glucose homeostasis. Blood samples were obtained by retroorbital 
bleeding at time of dissection after fasting (0800–1300 hours). Plas-
ma was prepared by centrifugation of whole blood at 3,400g for 10 
minutes at 4°C for glucose and insulin measurements (50). HOMA-IR 
was calculated using the following equation: ([glucose mmol/L × insu-
lin microunits/mL]/22.5).
Glucose tolerance tests were performed after 10 weeks of a high-
fat diet. After fasting (0800–1300 hours), mice were administered an 
intraperitoneal glucose bolus (2 mg per gram body weight). Glucose 
measurements were performed at 0, 15, 30, 60, 120, and 180 minutes 
with an AlphaTrak Glucometer by tail nick.
Quantitative RT-PCR. Gonadal and inguinal fat tissues were 
flash-frozen in liquid nitrogen and stored at –80°C. RNA was isolat-
ed from tissue using TRIzol (Life Technologies). First-strand cDNA 
was generated with iScript (Bio-Rad). Quantitative reverse-tran-
scription PCR (RT-PCR) was performed with a Bio-Rad CFX Con-
nect Real-Time PCR Detection System using SsoAdvanced SYBR 
Green Supermix and 36B4 mRNA as a normalization control. Prim-
ers were as follows: Kdm5c (ACCCACCTGGCAAAAACATTGG, 
ACTGTCGAAGGGGGATGCTGTG); Ddx3x (GGATCACGGGGT-
GATTCAAGAGG, CTATCTCCACGGCCACCAATGC); Kdm6a 
(CCAATCCCCGCAGAGCTTACCT, TTGCTCGGAGCTGTTC-
CAAGTG); Eif2s3x (TTGTGCCGAGCTGACAGAATGG, CGACAG-
GGAGCCTATGTTGACCA); and 36B4 (AGATGCAGCAGATCCG-
CAT, GTTCTTGCCCATCAGCACC).
GTEx human gene expression data. Gene expression data for 
KDM5C was obtained from the Genotype-Tissue Expression (GTEx) 
Consortium, a large-scale RNA-Seq project that characterized the 
human transcriptome across numerous tissues obtained from hun-
dreds of human donors as postmortem samples (51, 52).
Adipose tissue histology. Adipose tissues were fixed overnight in 
10% formalin. Sections of 7 μm were obtained and stained with H&E 
at the UCLA Translational Pathology Core Laboratory. For adipocyte 
area measurements, sections were digitalized (Zeiss Observer D1 
with ×10 objective) and the cell surface quantified with the Adiposoft 
plugin in FIJI in arbitrary units (53). Frequency counts were performed 
using bins at increments of 250.
Adipose tissue fractionation and Western blot analysis. Adipose tis-
sue from 2 mice was pooled and minced in digestion buffer (100 mM 
HEPES, 120 mM NaCl, 50 mM KCl, 5 mM glucose, 1 mM CaCl2, 1.5% 
BSA) containing 20 mg/mL collagenase I (MilliporeSigma). After 1 hour 
digestion at 37°C, the sample was filtered through a 70 μm mesh and 
debris was pelleted at 50g. The supernatant and top fat layer were spun 
at 200g to separate the stromal vascular (pellet) and mature adipocyte 
(top layer) fractions. Each fraction was resuspended in 100 μl lysis buf-
fer (10 mM Tris pH 7.5, 10 mM NaCl, 1 mM EDTA, 0.5% Triton X-100) 
containing protease and phosphatase inhibitors. Protein levels were 
analyzed by Western blot as described (54). Primary antibodies used 
were as follows: KDM5C (Active Motif, catalog 39229), FABP4 (Abcam, 
catalog ab92501), and GAPDH (GeneTex, catalog GTX100118).
of gene expression in fibroblasts, in cardiomyocyte differentiation, 
and in renal cell carcinomas (45–47). KDM5C and KDM5D proteins 
exhibit conserved protein domains for histone demethylase activ-
ity, but experimentally determined H3K4 demethylase activity 
appeared substantially lower for KDM5D than KDM5C (48). Thus, 
it is possible that the physiological roles of Kdm5c and Kdm5d genes 
are not equivalent due to differences in protein activity, gene regu-
lation, and/or other factors. Further studies to determine the physi-
ological roles of such X-Y gene pairs should shed additional light on 
the regulation of sexually dimorphic traits.
In conclusion, our findings highlight the effects of sex chro-
mosome complement — and particularly, the special class of X 
chromosome genes that escape inactivation — on sex differences 
in metabolism. Our studies demonstrate that sexual imbalance 
in Kdm5c expression levels influence diet-induced adipose tissue 
accrual. The experimental reduction of Kdm5c genomic dosage in 
XX females to that which is normally present in XY males led to 
reduced diet-induced adipose tissue expansion, likely regulated 
by changes in gene expression in processes such as ECM reorga-
nization. Further studies will assess the potential contribution of 
KDM5C levels to processes that rely upon successful adipose tis-
sue expansion, such as pregnancy, as well as the role of sex differ-
ences in Kdm5c gene dosage in tissues beyond adipose tissue.
Methods
Animals. FCG C57BL/6J mice were from a colony maintained at 
UCLA. XX female mice were mated with XY–(Sry+) male mice to 
generate XX, XX(Sry+), XY–, and XY–(Sry+) offspring. Genotyping 
was performed by PCR to detect the presence of the Sry transgene 
(forward: AGCCCTACAGCCACATGATA; reverse: GTCTTGCCT-
GTATGTGATGG) and Y chromosome–specific sequence (forward: 
CTGGAGCTCTACAGTGATGA; reverse: CAGTTACCAATCAACA-
CATCAC) (14).
Floxed Kdm5c mice have been described previously (49). At 
UCLA, floxed Kdm5c mice were backcrossed to C57BL/6J to gener-
ation N11 and then crossed with C57BL/6J Ella:Cre mice (Jackson 
Laboratory) to generate heterozygous knockouts of the floxed allele 
through Cre-lox recombination. Subsequent generations were crossed 
with C57BL/6J mice to eliminate Cre and the floxed allele. Because 
male Kdm5/–/Y mice were not viable on a C57BL/6 inbred background, 
we studied female XX Kdm5c+/+ and Kdm5c+/– mice produced by mat-
ing Kdm5c+/– females with WT males.
FCG mice were housed 2 per cage with identical genotypes, and 
mice of the Kdm5c gene dosage model were housed 2–4 per cage. All 
mice were maintained under a 12-hour light/12-hour dark cycle. Mice 
were initially fed a Purina Rodent Laboratory Chow diet containing 
5%–6% fat from calories (Purina 5001). Where indicated, adult FCG 
and Kdm5c mice were fed a high-fat diet (S3282, Bio-Serve; 60% calo-
ries from fat, 26% from carbohydrate, 15% from protein).
Body composition and energy balance. Mice were weighed at weekly 
intervals. Body composition was measured on conscious mice using a 
Mouse Minispec apparatus with Echo Medical Systems software. Food 
intake was measured per cage over three 24-hour periods at 0800 
and 1800 hours. Mice were housed individually in calibrated Oxymax 
metabolic chambers (Columbus Instruments) to detect O2 consump-
tion, CO2 production, locomotor activity, and heat production over 72 
hours at weeks 1 and 10 of the high-fat diet. Mice had ad libitum access 
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NovaSeq 6000 S2 at an average read depth of 40 × 106 reads/sample at 
the UCLA Technology Center for Genomics and Bioinformatics.
ATAC-Seq fastq files were trimmed to remove low-quality reads 
and adapters using Cutadapt, version 2.3 (code.google.com/p/cut-
adapt/). The reads were aligned to the reference mouse GRCm38/
mm10 genome with bowtie2, version 2.2.9 (57); typical alignment was 
greater than 95%. Peak calling was performed with model-based anal-
ysis of ChIP-Seq (MACS2, version 2.1.1) with a q value of 0.05 (58). 
The peaks for each experimental group were merged into a single bed 
file, and HTseq, version 0.9.1, was used to count the number of reads 
that overlap each peak per sample (59). The peak counts were ana-
lyzed with DESeq2, version 1.24.0, to identify differentially accessible 
genomic regions, with significance counted as P < 0.05 (60). The peak 
counts were visualized with IGV, version 2.6.2 (61). The genomic loca-
tions of the peaks were determined and visualized with ChIPseeker, 
version 1.20.0. (62). ATAC-Seq of 3T3-L1 cells was performed with n = 
4 control and n = 4 Kdm5c knockdown samples.
Pathway enrichment analysis. Pathway analysis for RNA-Seq data 
was performed with Enrichr (63, 64) for the differentially expressed 
genes with adjusted P < 0.05 and fold change greater than 1.25. Path-
way analysis for ATAC-Seq was performed using peaks with greater 
than 1.5-fold change upon Kdm5c knockdown and that corresponded 
to genes that were differentially expressed (adjusted P < 0.05) in the 
day 0 RNA-Seq analysis.
Human gene expression association analyses. RNA-Seq data from 
subcutaneous adipose tissue punch biopsies were available for 766 
twins from the TwinsUK study (27). RNA-Seq reads were aligned to the 
hg19 reference genome using STAR, version 2.4.0.1 (55), as previous-
ly described (65). Gene and exon-level quantification was conducted 
using the Quan tool in the QTLtools package (66). TMM-value normal-
ization (67) was applied to exon counts, and TMM-normalized counts 
per million (CPMs) were then inverse normalized. Subjects who had 
not fasted on the day of biopsy were excluded from all further analyses. 
Inverse normal transformation was applied to all quantitative traits.
For gene expression association analysis, a mixed effects model 
was then fitted using the lmer function from the lme4 package (68) 
in R, version 3.3.2. Inverse-normalized exon counts for each exon 
were treated as a continuous dependent variable and BMI as an inde-
pendent variable. Covariates added to the model included age, time 
since last meal, mean GC content, median insert size, and median 
transcript integrity number (69) as fixed effects; and morning versus 
afternoon appointment time, date of RNA-Seq, RNA extraction batch, 
primer index, family,and zygosity as random effects. Significance was 
calculated by comparing the full model, including BMI, to a null model 
in which BMI was omitted, using a 1 degree of freedom ANOVA.
Human genetic association. We tested SNPs in Multi-Ethnic Study 
of Atherosclerosis (MESA) 1000G phase 1 imputed data at the KDM5C 
gene locus (Chr:53220000–53254604, genome release GRCh37/
hg19) if the sample size in the minor allele carrier group was 10 or 
greater. MESA has 4 population samples: AA, HA, Han Chinese, and 
EA, with a sample size of 385–1400 in each ethnic/sex group. The 
number of SNPs in the KDM5C gene that met the minimum sample 
requirement for association analysis was different for each popula-
tion and between men and women. Power analyses performed using 
QUANTO (https://bio.tools/QUANTO) showed that in samples that 
contained at least 700 individuals/ethnic group/sex, we had 87% 
power to detect association if a SNP explained 3% of the phenotypic 
Kdm5c knockdown in 3T3-L1 preadipocytes. 3T3-L1 preadipocytes 
(Zen-Bio; karyotype XY, 2n = 40, but diploid chromosome number 
may be unstable) were reverse-transfected with 50 nM nontargeting 
(control) or Kdm5c siRNA (Dharmacon) with Lipofectamine RNAi-
MAX (Thermo Fisher Scientific) at differentiation day –3 (subconflu-
ent) or –2 (confluent). For RNA isolation (transcriptome analysis) and 
nucleus isolation (ATAC-Seq), cells were collected at 24 hours (day –2), 
48 hours (day –1), and 72 hours (day 0) after transfection. For prolifer-
ation analysis, cells were replated at a low density 24 hours after trans-
fection and cell counts were performed every 24 hours. For analysis 
of differentiation, differentiation medium was added on day 0 and 
maintenance medium (all adipocyte media obtained from Zen-Bio) 
was added on day 2. At day 6, cells were formalin fixed, washed with 
60% isopropanol, and stained with ORO (0.20% w/v). After imaging 
stained cells, ORO was solubilized with 100% isopropanol and quan-
tified by spectrophotometry at an OD of 500 nm.
RNA-Seq analysis. Total RNA was isolated from 3T3-L1 cells or 
fractionated adipose tissue (mature adipocytes or stromal vascular 
cells) with miRNeasy Micro Kit (QIAGEN), and integrity was assessed 
with the 4200 TapeStation System (Agilent). Strand-specific RNA-
Seq libraries were constructed with the Universal Plus mRNA-Seq 
Kit (NuGEN Technologies). The workflow consisted of poly(A) RNA 
selection, RNA fragmentation, and double-stranded cDNA synthe-
sis with a mixture of random and oligo(dT) priming, followed by end 
repair to generate blunt ends, adaptor ligation, strand selection, and 
PCR amplification to produce the final libraries. Amplified libraries 
were quantified by Qubit dsDNA High Sensitivity Assay Kit and qual-
ity checked with the 4200 TapeStation System (Agilent). Different 
index adaptors were used for multiplexing samples, and sequencing 
was performed with Illumina NovaSeq 6000 sequencer on a NovaSeq 
S2 flow cell to produce 50 bp paired-end reads (2 × 50 bp). RNA-Seq 
alignment was performed with STAR, version 2.7.2a, to the mouse 
genome GRCm38.97, and the read count per gene was quantified with 
STAR and the Ensembl Mus_musculus.GRCm38.97 GTF file (55). The 
average read depth was 36 × 106 reads/sample, and an average of 86% 
of reads was uniquely aligned to the genome.
Differential gene expression was identified with EdgeR, version 
3.26.8, with trimmed mean of M values (TMM) normalization and 
significance denoted as adjusted P < 0.05. Heatmaps were generated 
with gplots heatmap.2, version 3.0.1.1, and volcano plots with custom-
ized R function. RNA-Seq of 3T3-L1 cells was performed with n = 4 
control and n = 4 Kdm5c knockdown samples; RNA-Seq of fraction-
ated mouse tissues was performed with stromal vascular and mature 
adipocyte samples from 3 Kdm5c+/+ and 3 Kdm5c+/– mice.
ATAC-Seq analysis. For ATAC-Seq, 50,000 cells per sample were 
lysed to collect nuclei and treated with Tn5 transposase (Illumina) for 
30 minutes at 37°C with gentle agitation, as previously described (56). 
The DNA was isolated with DNA Clean & Concentrator Kit (Zymo) and 
PCR amplified and barcoded with NEBNext High-Fidelity PCR Mix 
(New England Biolabs) and unique dual indexes (Illumina). The ATAC-
Seq library amplification was confirmed by real-time PCR, and addi-
tional barcoding PCR cycles were added as necessary while avoiding 
overamplification. Amplified ATAC-Seq libraries were purified with 
DNA Clean & Concentrator Kit (Zymo). The purified libraries were 
quantified with Kapa Library Quant Kit (KAPA Biosystems) and qual-
ity assessed on 4200 TapeStation System (Agilent). The libraries were 
pooled based on molar concentrations and sequenced on an Illumina 
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Study approval. Mouse studies were conducted in accordance 
with and were approved by the Institutional Animal Research Com-
mittee of UCLA. The TwinsUK project was approved by the Ethics 
Committee at St Thomas’ Hospital London, where all the biopsies 
were carried out. Volunteers gave informed consent and signed an 
approved consent form before biopsy procedures. Volunteers were 
supplied with an appropriate detailed information sheet regarding 
the research project and biopsy procedure by mail before biopsies 
were taken. All MESA participants provided informed consent, and 
the study was approved by the Institutional Review Board at the 
Lundquist Institute (formerly Los Angeles BioMedical Research 
Institute) at Harbor-UCLA Medical Center (IRB protocol 21030-01) 
or by the Institutional Review Board at the University of Washington 
(IRB protocol STUDY00009029).
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variance. We therefore carried out association analysis separately for 
men and women within the AA, HA, and EA groups, which have 
700 or more samples in each analysis group.
We assumed an additive model using linear regression, account-
ing for genotype imputation uncertainty. To adjust for potential con-
founding effect, we included age, age2, study site, and top 2 principle 
components (PC1, PC2) in the testing model. The plink.multivariate 
package in the PLINK program was used in the multivariate analysis 
for BMI-WHR (70). Given that Bonferroni’s correction is not appro-
priate here owing to LD structure, we used the Haploview program 
to investigate the LD structure within each population to define inde-
pendent blocks/SNPs to adjust for the number of independent tests. 
Ultimately, significant associations were identified for the AA and HA 
groups at α = 0.05, determined as follows: in AA men, there were 5 LD 
blocks and 2 independent SNPs; in AA women, there were 4 LD blocks 
and 27 independent SNPs; in HA men, there were 2 LD blocks and 4 
independent SNPs; and in HA women, there was 1 LD block (Supple-
mental Figure 6). We used P value cutoffs for significant association 
as follows: 0.05/(no. of independent blocks + SNPs)/4 study popula-
tions, i.e., 0.0014 ( = 0.05/(5 +2 )/4) for AA men; 0.0004 (P = 0.05/(4 
+ 27)/4) for AA women; 0.0021 (P = 0.05/(2 + 4)/4) for HA men; and 
0.0125 (P = 0.05/1/4) for HA women.
Availability of data, code, and biological materials. Data sets have 
been deposited in relevant databases. RNA-Seq and ATAC-Seq data 
associated with Figures 5 and 6 are available in NCBI’s Gene Expres-
sion Omnibus database (GEO GSE147994, GSE147997, GSE147998). 
The human subjects data associated with Table 1 are available in 
dgGAP (phs000209.v13.p3).
Code used for analysis of RNA-Seq and ATAC-Seq is all freely 
available from developers, as cited in the Methods section. Data anal-
yses were performed with the following: RNA-Seq alignment with 
STAR, version 2.4.0.1 or version 2.7.2a; differential gene expression 
with EdgeR, version 3.26.8; heatmap generation with gplots heat-
map.2, version 3.0.1.1; volcano plots with customized R function; Cut-
adapt, version 2.3 for ATAC-Seq fastq file trimming; read alignment 
with bowtie2, version 2.2.9; ATAC-Seq peak calling with MACS2, ver-
sion 2.1.1; peak merging with HTseq, version 0.9.1; differential peak 
counts with DESeq2, version 1.24.0; peak visualization with IGV, ver-
sion 2.6.2; peak genomic location with ChIPseeker, version 1.20.0; 
pathway enrichment analysis with Enrichr; human gene and exon-lev-
el quantitation with Quan tool in the QTLtools package; gene expres-
sion association analysis using Ime4; power analysis for human SNPs 
performed using QUANTO; multivariate analysis with PLINK; and LD 
structure with Haploview.
We will provide mouse strains and cell lines described in this 
study upon request to noncommercial entities for research purposes 
in agreement with University of California regulations.
Statistics. In mouse studies, groups were compared using 2-factor 
ANOVA (NCSS) with main factors of sex (gonadal male vs. gonadal 
female) and sex chromosome complement (XX vs. XY), and pairs were 
compared using Student’s t test (2 tailed). For growth curves and the 
glucose tolerance test, repeated measures ANOVA was performed 
using time as a variable. For in vitro studies, pairs were assessed with 
Mann-Whitney nonparametric U tests, and groups were compared 
using 2-factor ANOVA. Statistically significant comparisons or inter-
actions are presented, with significance defined as P < 0.05. All error 
bars represent 1 SD.
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